PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentWhy the mitochondria debate shouldn't be left to the popular media

BioNews

Why the mitochondria debate shouldn't be left to the popular media

Published 14 October 2012 posted in Comment and appears in BioNews 662

Author

Virginia Bolton

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

Predictably, the publication of the Nuffield Council on Bioethics' report supporting further research into a technique to prevent inheritance of mitochondrial disease prompted a flurry of publicity. Equally predictably, nearly every newspaper - whether broadsheet or tabloid - went for the sensationalist angle and used the 'three-parent IVF' tag in their headline...

Predictably,
the publication of the Nuffield Council on Bioethics' report (1) supporting
further research into a technique to prevent inheritance of mitochondrial
disease prompted a flurry of publicity. Equally predictably, nearly every newspaper
- whether broadsheet or tabloid - went for the sensationalist angle and used
the 'three parent IVF' tag in their headline. The exceptions were the Guardian (2)
and the Northern Echo (3).

These
were the only newspapers to respond in print to the pleas of the experts
involved in the discussions, who have asked repeatedly that 'all efforts should be made to discourage sensational
interpretation' (4). Indeed, in his comment
in BioNews last week (5), Dr Geoff Watts, who chaired the Nuffield working
group, referred to the 'three parent froth', and noted in resigned tones that
this debate now seems doomed to be labelled in this way.

Yet, as he pointed out, this distracts from the far more
significant issue raised by the potential treatment strategy under discussion,
namely that of moving a nucleus from one egg to another. This touches for the
first time on the issue of changing the genetic material, albeit a minuscule
amount, of the female offspring in future generations. The genetic material in
question is restricted to the organelles in the cytoplasm that provide cells
with energy, the mitochondria.

There is no escaping the fact that this takes us into a new
realm in terms of therapy; as Dr Watts says, 'it does cross a line'. Our
responsibility, therefore, is to ensure that further debate establishes beyond
doubt that what is under discussion is distinct from interference with the
nuclear germline; the debate concerns a technique that will enable faulty
mitochondria in the egg cytoplasm to be replaced with healthy ones, but along
with the mitochondria will go the tiny amount of DNA they carry.

Further discussion of this topic is imminent, because the Human Fertilisation
and Embryology Authority (HFEA) has been asked by Secretary of State for Health
and the Secretary of State for Business, Innovation and Skills to seek public
views on the development of the same technique that was considered by the
Nuffield consultation (6).

The
HFEA's public consultation will be launched in September this year, preceded in
July by a series of events across the UK that will give members of the public
the opportunity to discuss the issues in a bit more depth. With a chance for
people to come together, share their views and explore the real issues, it is
essential that these discussions are informed and level-headed, and not
obscured or distorted by the media's penchant for sensational catchphrases.

As a society, we have come so far since the 1980s, when
public opinion was influenced by figures like Enoch Powell. His Unborn Children
(Protection) bill posed a very real threat to any further innovation, any research,
or the development of treatment options for the infertile or families suffering
from the blight of inherited disease. The change has come through raised
awareness, information and education, familiarity, and demystification of the
field of reproductive technology. We owe it to those who campaigned in the 1980s
and 1990s, and to future generations, to ensure that the level of discussion
during this forthcoming HFEA consultation is intelligent, informed and
pertinent to the real issues.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
10 April 2013 • 2 minutes read

Mitochondria in the spotlight

by Sarah Norcross

Mitochondria don't normally get much press attention, they like to keep a low profile generating energy in the cells and leave nuclear DNA to grab the headlines...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
10 April 2013 • 2 minutes read

HFEA launches public consultation on mitochondrial replacement techniques

by Dr Sophie Pryor

The UK's Human Fertilisation and Embryology Authority (HFEA) has launched a public consultation on the social and ethical impact of new methods that could prevent the transmission of some incurable mitochondrial diseases....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 March 2013 • 3 minutes read

Nuffield Council gives green light to the prevention of inherited mitochondrial disease

by Dr Antony Starza-Allen

The Nuffield Council on Bioethics has published a review of the ethical issues raised by proposed IVF techniques, which aim to prevent the transmission of faulty mtDNA from mother to child. The report concludes the techniques are ethically permissible, provided further research establishes their safety....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
30 January 2013 • 4 minutes read

Beyond the treatment of infertility

by Professor Mary Herbert

The advent of PGD extended the scope of IVF beyond the treatment of infertility. PGD is predominantly used to prevent transmission of genetic defects arising from mutations in nuclear DNA. However, it can also be used to reduce the risk of transmitting mutations in mitochondrial DNA (mtDNA), which cause a range of debilitating and life-threatening diseases...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
30 January 2013 • 3 minutes read

Why we should back a law change to allow mitochondrial transfer into the clinic

by Dr Kristina Elvidge

Mitochondrial diseases are soon to be brought to the attention of the general public, as the Government seeks to gauge the attitude of the nation towards a ground-breaking IVF treatment that could prevent these conditions being passed from mother to child...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 January 2013 • 2 minutes read

£5.8m boost for mitochondrial disease research

by Dr Maria Botcharova

An experimental genetic technique to prevent serious diseases from passing between mother and child is to receive £5.8 million funding. The Wellcome Trust is contributing £4.4 million to the new Centre for Mitochondrial Research at Newcastle University...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
3 December 2012 • 4 minutes read

Event Review: Have Your Say on Mitochondria Replacement (London)

by Sandy Starr

At the beginning of this year, the Human Fertilisation and Embryology Authority was asked to consult the public on proposed new techniques to avoid the transmission of mitochondrial disease. The resulting public consultation is being conducted in several different ways including two public events, the first of which I attended...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 October 2012 • 2 minutes read

Mitochondrial DNA replacement therapy successfully tested in human eggs

by Joe Jebelli

Scientists have successfully created human embryos containing donated mitochondrial DNA in an effort to stop children inheriting life-threatening diseases...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
5 October 2012 • 5 minutes read

Freeing us from our cells: avoiding inherited mitochondrial disease

by Dr Sophie Pryor

On 25 September 2012 the Progress Educational Trust held a debate on the issues surrounding new techniques to prevent the transmission of mitochondrial disease. The event was organised in partnership with City University London's science journalism course and was supported by the Wellcome Trust....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
Comment
18 June 2009 • 3 minutes read

Healthy babies with two parents (oh, and a tiny bit of DNA from someone else)

by Virginia Bolton

This week saw another very positive illustration of the rigour and effectiveness of the regulatory system that exists in the UK to licence research using human embryos. However, it also highlighted ambiguities in the wording of the 1990 Human Fertilisation and Embryology Act, which is currently the focus of a...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« An eggsample of why it is hard to prove a negative

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Recent
4 July 2022 • 4 minutes read

Widening the debate about direct-to-consumer genetic testing and donor conception

4 July 2022 • 3 minutes read

Join PET and Genomics England to celebrate the 200th birthday of Gregor Mendel

27 June 2022 • 4 minutes read

Thirty years of PET: our 'Fertility, Genomics and Embryo Research' report

27 June 2022 • 5 minutes read

Children's rights and donor conception: What next?

20 June 2022 • 4 minutes read

The problems with lifting donor anonymity earlier

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856